Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Subcutaneous (under the skin) with an insulin syringe
Tirzepatide has undergone clinical trials to assess its safety and efficacy
For pediatric patients, instruct patients who miss a dose of TRESIBA to contact their healthcare provider for guidance and to monitor blood glucose levels more frequently until the next scheduled TRESIBA dose
The timeline varies depending on the individual, but studies show some patients may lose around 20 pounds within a few months when using tirzepatide as part of a medically supervised weight management plan
US$ 22.33
US$ 24.10
US$ 21.87
US$ 23.44
